Drug profile · INN
vasopressin tannate
PITRESSIN TANNATE
vasopressin tannate (PITRESSIN TANNATE) is a vasopressin v1a receptor agonist. Route of administration: injection. Current US regulatory status: approved.
Drug details — vasopressin tannate
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
vasopressin tannate (PITRESSIN TANNATE) is a vasopressin v1a receptor agonist. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Vasopressin V1a receptor agonist
Primary target: Vasopressin V1a receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is vasopressin tannate?
vasopressin tannate (PITRESSIN TANNATE) is a vasopressin v1a receptor agonist. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for vasopressin tannate?
PITRESSIN TANNATE is a marketed brand name for vasopressin tannate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of vasopressin tannate?
vasopressin tannate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.